Catalyst Wire Dossier Catalyst Wire Dossier

Litak

cladribine · Lipomed GmbH
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Litak, covering 2025-04-03 to 2025-04-03. Get the full timeline:

Most recent: EMA Authorised: Litak (cladribine) — Lipomed GmbH

See pricing